▶ 調査レポート

世界のリソソーム酸性リパーゼ欠損症（LAAL）治療市場規模・現状・予測（2021年-2027年）
• 英文タイトル：Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2021-2027

Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2021-2027「世界のリソソーム酸性リパーゼ欠損症（LAAL）治療市場規模・現状・予測（2021年-2027年）」（市場規模、市場予測）調査レポートです。• レポートコード：QYR2104Z3507
• 出版社/出版日：QYResearch / 2021年4月10日
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User/Five User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License（同一法人内共有可）￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
QYResearch社発行の本調査資料では、リソソーム酸性リパーゼ欠損症（LAAL）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、腎臓移植、幹細胞移植）、用途別市場規模（ウォルマン病、コレステリルエステル蓄積症（CESD））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・リソソーム酸性リパーゼ欠損症（LAAL）治療の市場動向
・企業の競争状況、市場シェア
・リソソーム酸性リパーゼ欠損症（LAAL）治療の種類別市場規模（酵素補充療法、腎臓移植、幹細胞移植）
・リソソーム酸性リパーゼ欠損症（LAAL）治療の用途別市場規模（ウォルマン病、コレステリルエステル蓄積症（CESD））
・リソソーム酸性リパーゼ欠損症（LAAL）治療の北米市場規模2016-2027（アメリカ、カナダ）
・リソソーム酸性リパーゼ欠損症（LAAL）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・リソソーム酸性リパーゼ欠損症（LAAL）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・リソソーム酸性リパーゼ欠損症（LAAL）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・リソソーム酸性リパーゼ欠損症（LAAL）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca plc、Merck & Co., Inc、Pfizer, Inc.、Alexion Pharmaceutical Inc、Lonza Group Ltd.、hermo Fisher Scientific、Teva Pharmaceutical Industries Ltd.）
・結論

Market Analysis and Insights: Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market
The global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market.

Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Scope and Market Size
Lysosomal Acid Lipase Deficiency (LAAL) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Enzyme Replacement Therapy
Kidney Transplantation
Stem Cell Transplantation

Segment by Application
Wolman Disease
Cholesterol Ester Storage Disease (CESD)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca plc
Merck & Co., Inc
Pfizer, Inc.
Alexion Pharmaceutical Inc
Lonza Group Ltd.
hermo Fisher Scientific
Teva Pharmaceutical Industries Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enzyme Replacement Therapy
1.2.3 Kidney Transplantation
1.2.4 Stem Cell Transplantation
1.3 Market by Application
1.3.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Wolman Disease
1.3.3 Cholesterol Ester Storage Disease (CESD)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Perspective (2016-2027)
2.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Growth Trends by Regions
2.2.1 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Industry Dynamic
2.3.1 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Trends
2.3.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Drivers
2.3.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Challenges
2.3.4 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lysosomal Acid Lipase Deficiency (LAAL) Treatment Players by Revenue
3.1.1 Global Top Lysosomal Acid Lipase Deficiency (LAAL) Treatment Players by Revenue (2016-2021)
3.1.2 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue
3.4 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Concentration Ratio
3.4.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue in 2020
3.5 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Players Head office and Area Served
3.6 Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product Solution and Service
3.7 Date of Enter into Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Breakdown Data by Type
4.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Forecasted Market Size by Type (2022-2027)

5 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Breakdown Data by Application
5.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2016-2027)
6.2 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
6.2.1 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021)
6.2.2 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027)
6.2.3 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2027)
6.3 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application
6.3.1 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021)
6.3.2 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027)
6.3.3 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2027)
6.4 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country
6.4.1 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2016-2021)
6.4.2 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2016-2027)
7.2 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
7.2.1 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2027)
7.3 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application
7.3.1 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2027)
7.4 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country
7.4.1 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
8.2.1 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application
8.3.1 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Region
8.4.1 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2016-2027)
9.2 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
9.2.1 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2027)
9.3 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application
9.3.1 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2027)
9.4 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country
9.4.1 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
10.2.1 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application
10.3.1 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country
10.4.1 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Details
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
11.1.4 AstraZeneca plc Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
11.1.5 AstraZeneca plc Recent Development
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Details
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
11.2.4 Merck & Co., Inc Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
11.2.5 Merck & Co., Inc Recent Development
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Details
11.3.2 Pfizer, Inc. Business Overview
11.3.3 Pfizer, Inc. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
11.3.4 Pfizer, Inc. Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
11.3.5 Pfizer, Inc. Recent Development
11.4 Alexion Pharmaceutical Inc
11.4.1 Alexion Pharmaceutical Inc Company Details
11.4.2 Alexion Pharmaceutical Inc Business Overview
11.4.3 Alexion Pharmaceutical Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
11.4.4 Alexion Pharmaceutical Inc Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
11.4.5 Alexion Pharmaceutical Inc Recent Development
11.5 Lonza Group Ltd.
11.5.1 Lonza Group Ltd. Company Details
11.5.2 Lonza Group Ltd. Business Overview
11.5.3 Lonza Group Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
11.5.4 Lonza Group Ltd. Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
11.5.5 Lonza Group Ltd. Recent Development
11.6 hermo Fisher Scientific
11.6.1 hermo Fisher Scientific Company Details
11.6.2 hermo Fisher Scientific Business Overview
11.6.3 hermo Fisher Scientific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
11.6.4 hermo Fisher Scientific Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
11.6.5 hermo Fisher Scientific Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Details
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Kidney Transplantation
Table 4. Key Players of Stem Cell Transplantation
Table 5. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Regions (2016-2021)
Table 9. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Regions (2022-2027)
Table 11. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Trends
Table 12. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Drivers
Table 13. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Challenges
Table 14. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Restraints
Table 15. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Players (2016-2021)
Table 17. Global Top Lysosomal Acid Lipase Deficiency (LAAL) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment as of 2020)
Table 18. Ranking of Global Top Lysosomal Acid Lipase Deficiency (LAAL) Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product Solution and Service
Table 22. Date of Enter into Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca plc Company Details
Table 63. AstraZeneca plc Business Overview
Table 64. AstraZeneca plc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product
Table 65. AstraZeneca plc Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca plc Recent Development
Table 67. Merck & Co., Inc Company Details
Table 68. Merck & Co., Inc Business Overview
Table 69. Merck & Co., Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product
Table 70. Merck & Co., Inc Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021) & (US$ Million)
Table 71. Merck & Co., Inc Recent Development
Table 72. Pfizer, Inc. Company Details
Table 73. Pfizer, Inc. Business Overview
Table 74. Pfizer, Inc. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product
Table 75. Pfizer, Inc. Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer, Inc. Recent Development
Table 77. Alexion Pharmaceutical Inc Company Details
Table 78. Alexion Pharmaceutical Inc Business Overview
Table 79. Alexion Pharmaceutical Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product
Table 80. Alexion Pharmaceutical Inc Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021) & (US$ Million)
Table 81. Alexion Pharmaceutical Inc Recent Development
Table 82. Lonza Group Ltd. Company Details
Table 83. Lonza Group Ltd. Business Overview
Table 84. Lonza Group Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product
Table 85. Lonza Group Ltd. Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021) & (US$ Million)
Table 86. Lonza Group Ltd. Recent Development
Table 87. hermo Fisher Scientific Company Details
Table 88. hermo Fisher Scientific Business Overview
Table 89. hermo Fisher Scientific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product
Table 90. hermo Fisher Scientific Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021) & (US$ Million)
Table 91. hermo Fisher Scientific Recent Development
Table 92. Teva Pharmaceutical Industries Ltd. Company Details
Table 93. Teva Pharmaceutical Industries Ltd. Business Overview
Table 94. Teva Pharmaceutical Industries Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product
Table 95. Teva Pharmaceutical Industries Ltd. Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd. Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Enzyme Replacement Therapy Features
Figure 3. Kidney Transplantation Features
Figure 4. Stem Cell Transplantation Features
Figure 5. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application: 2020 VS 2027
Figure 6. Wolman Disease Case Studies
Figure 7. Cholesterol Ester Storage Disease (CESD) Case Studies
Figure 8. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Report Years Considered
Figure 9. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Regions (2022-2027)
Figure 13. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Players in 2020
Figure 14. Global Top Lysosomal Acid Lipase Deficiency (LAAL) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue in 2020
Figure 16. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2016-2027)
Figure 20. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2016-2027)
Figure 21. North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Country (2016-2027)
Figure 22. United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2016-2027)
Figure 26. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2016-2027)
Figure 27. Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Country (2016-2027)
Figure 28. Germany Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Region (2016-2027)
Figure 38. China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca plc Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
Figure 58. Merck & Co., Inc Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
Figure 59. Pfizer, Inc. Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
Figure 60. Alexion Pharmaceutical Inc Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
Figure 61. Lonza Group Ltd. Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
Figure 62. hermo Fisher Scientific Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

関連レポート
  • 世界のサフランビール市場インサイト・予測（～2027年）
    Global Saffron Beer Market Insights and Forecast to 2027
    QY2112C02136 2021年12月15日 106Pages
    本調査資料はサフランビールの世界市場の現状について調査・分析し、2027年までの市場を予測しました。サフランビールの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（オーガニック、従来型）、用途別市場規模（飲料産業、醸造産業、健康・ウェルネス産業、パーソナルケア産業、その他）、主要地域...
  • 世界のコノテガシワ抽出物市場 2028年：錠剤、粉末、カプセル、その他
    Global Cacumen Platycladi Extract Market Insights, Forecast to 2028
    QY2207C0696 2022年7月15日 93Pages
    新型コロナウイルス感染症のパンデミックにより、世界のコノテガシワ抽出物の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にコノテガシワ抽出物...
  • 世界のハイブリッド電気自動車（HEV）用電気めっき試薬市場 2028年：酸めっき試薬、アルカリめっき試薬
    Global Electroplating Reagents for Hybrid Electric Vehicles (HEVs) Market Insights, Forecast to 2028
    QY2207C0258 2022年7月15日 94Pages
    新型コロナウイルス感染症のパンデミックにより、世界のハイブリッド電気自動車（HEV）用電気めっき試薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、...
  • 世界のシチコリンナトリウム市場 2028年：純度≥98％、純度≥99％
    Global Citicoline Sodium Market Insights, Forecast to 2028
    QY2207C0849 2022年7月8日 94Pages
    新型コロナウイルス感染症のパンデミックにより、世界のシチコリンナトリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にシチコリンナトリ...
  • ポリブチレンサクシネート(PBS)のグローバル市場インサイト・予測（～2028年）
    Global Poly Butylene Succinate(PBS) Market Insights and Forecast to 2028
    QY2203B06288 2022年3月18日 112Pages
    新型コロナウイルス感染症のパンデミックにより、世界のポリブチレンサクシネート(PBS)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にポ...
  • キーボード保護材（キーボードスキン）のグローバル市場インサイト・予測（～2028年）
    Global Keyboard Protector(Keyboard Skin) Market Insights and Forecast to 2028
    QY2203B02423 2022年3月18日 110Pages
    新型コロナウイルス感染症のパンデミックにより、世界のキーボード保護材（キーボードスキン）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...
  • リアクティブオレンジ35のグローバル市場インサイト・予測（～2028年）
    Global Reactive Orange 35 Market Insights, Forecast to 2028
    QY2203B06937 2022年3月18日 95Pages
    新型コロナウイルス感染症のパンデミックにより、世界のリアクティブオレンジ35の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にリアクティブ...
  • 世界のシュウ酸ネオジム市場インサイト・予測（～2027年）
    Global Neodymium Oxalate Market Insights and Forecast to 2027
    QY2112C00583 2021年12月15日 98Pages
    本調査資料はシュウ酸ネオジムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。シュウ酸ネオジムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99％、純度99.9％、純度99.99％、純度99.999％）、用途別市場規模（マグネット製造、ガラス製造、その...
  • 世界のリングスピンドル市場インサイト・予測（～2027年）
    Global Ring Spindle Market Insights and Forecast to 2027
    QY2112C03137 2021年12月15日 96Pages
    本調査資料はリングスピンドルの世界市場の現状について調査・分析し、2027年までの市場を予測しました。リングスピンドルの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（手動ドッフィング用スピンドル、自動ドッフィング用スピンドル、その他）、用途別市場規模（紡績業、その他）、主要地域別市...
  • 世界のカーボンファイバーフェルト市場 2028年：ポリアクリロニトリルベース炭素繊維フェルト、粘性ベース炭素繊維フェルト、アスファルトベース炭素繊維フェルト
    Global Carbon Fiber Felt Market Insights, Forecast to 2028
    QY2207C0729 2022年7月15日 115Pages
    新型コロナウイルス感染症のパンデミックにより、世界のカーボンファイバーフェルトの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカーボンフ...